Breaks Categories: News

ThursdayNov 02, 2023 1:42 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Provides Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared an open letter to shareholders from CEO David Michery, providing updates on various matters and company initiatives. In the letter, Michery highlights several recent company accomplishments, including its commencement of Class 1 EV cargo vans on Nov. 1, 2023. “Over the past few months, the company has reached critical milestones towards accomplishing our ultimate goal to be a leader in the EV industry,” Michery stated in the letter. “We remain steadfastly dedicated to our employees, stakeholders and customers during this journey and thank you for your continued support…

Continue Reading

ThursdayNov 02, 2023 12:40 pm

NetworkNewsBreaks — Lightning Motorcycle Announces Investor Discount Perk Program

Lightning Motorcycle, manufacturer of the world’s most advanced electric motorcycles, is committed to environmental consciousness as it works to build its transformative motorcycles that offer superior efficiency, performance and affordability. According to a recent release, the company believes that electric mobility is the key to a sustainable future and is committed to making this vision a reality through its ecofriendly offerings. The company recently announced a limited-time “special perk” investment program that gives investors a 20% perk of an invested amount with no minimum. Individuals can choose from a discount on an EV bike or Lightning Motorcycle swag, such as…

Continue Reading

ThursdayNov 02, 2023 12:22 pm

NetworkNewsBreaks – Diamond Lake Minerals Inc. (DLMI) Featured in Bell2Bell Podcast

Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company offering traditional investors an entry point to the future of digital securities, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Diamond Lake’s CEO Brian J. Esposito joined the program to discuss DLMI’s business model, operating markets and leadership team. “The best way I can describe what we’re building here at DLMI is an old-school General Electric/Berkshire Hathaway approach where we’re going to have an umbrella holding company of all of these wonderful subsidiaries across…

Continue Reading

ThursdayNov 02, 2023 11:58 am

NetworkNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD), Bourne Partners to Collaborate in Evaluating Future Monetization of Potential PRV

PaxMedica (NASDAQ: PXMD), a pioneering biopharmaceutical company focused on advancing treatments for neurologic disorders, is working with leading financial services firm Bourne Partners. Bourne Partners specializes in the pharma, pharma services and consumer health spaces. According to the announcement, the collaboration is an important step in PaxMedica's strategy to explore potential monetization of a Priority Review Voucher prior to filing the NDA for PAX-101 for the treatment of African Sleeping Sickness. Although PaxMedica has not yet been granted a PRV and there is no guarantee that one will be awarded, the company believes  PAX-101 qualifies for the PRV program because African Sleeping…

Continue Reading

ThursdayNov 02, 2023 10:41 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present Phase 2 Study Results for INM-755 at 12th Annual WCI

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be presenting an oral presentation at the 12th World Congress on Itch (“WCI”); the event is scheduled for Nov. 5–7, 2023, in Miami. According to the announcement, the oral presentation is based on an abstract describing the phase 2 clinical study of investigational drug INM-755 cannabinol cream for the treatment of symptoms in patients with rare genetic skin disease called epidermolysis bullosa ("EB"). InMed Pharmaceuticals senior vice president of Clinical and Regulatory Affairs Alexandra Mancini will be presenting. The…

Continue Reading

WednesdayNov 01, 2023 3:10 pm

NetworkNewsBreaks – Skyline Corporate Communications Group, LLC President Scott Powell Featured in Interview with TheStreet

Scott Powell, PR expert and president of Skyline Corporate Communications Group, recently joined TheStreet to discuss how companies should handle bad press. It has become clear that no company is immune to a PR crisis in the wake of the pride month backlash towards companies like Anheuser-Busch and Target. However, Powell discusses some best practices in dealing with the fallout. “It’s not always easy to handle a crisis, and this applies to a variety of different companies and crises. What we advise clients is don't remain silent. You have to say something. You know, it may be just that we’re…

Continue Reading

WednesdayNov 01, 2023 2:20 pm

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Now Taking Orders for Evolve(TM) Soft Bait

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, announced that it is now taking orders from commercial customers for Evolve(TM) Soft Bait (“Evolve(TM)”), a solution designed to reduce fertility in rats, for shipment on or before Nov. 13. According to the announcement, the company already has received advanced purchase commitments from key customers. “Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest(R), but in a format that is easier to deploy and that they can use daily in their integrated pest management programs,” said Joel Fruendt, SenesTech’s president…

Continue Reading

WednesdayNov 01, 2023 2:15 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at BIO-Europe 2023

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes, today announced that Catherine Vaczy, its EVP, general counsel and chief strategy officer, will be providing an overview of the company’s gene therapies for cancer and diabetes at the upcoming BIO-Europe 2023 Conference taking place in Munich, Germany. Vaczy’s presentation is slated to begin at 4:45 p.m UTC on Tuesday, Nov. 7, 2023. Several members of Genprex’s executive leadership team will be in attendance at BIO-Europe 2023. Those interested in meeting Genprex management during the event should request a meeting through…

Continue Reading

WednesdayNov 01, 2023 2:06 pm

NetworkNewsBreaks – RJD Green Inc. (RJDG) Reports on Annual Financial Results, Files Annual Report in Timely Manner

RJD Green (OTC: RJDG), a publicly traded company that operates as a holding company focusing on acquiring and managing assets, and actively exploring potential acquisitions and opportunities in diversified industries, has filed its annual report for the year ended Aug. 31, 2023. Notable results from the financial report include revenue totaling $5,019,239 and a net profit of $642,678, with cash and cash equivalents of $819,724 as of Aug. 31, 2023. The report also noted that the company has monthly recurring revenues of $418,269 with $2,455,631 in assets, liabilities of $334,039 as of the same date. The report noted that 2023…

Continue Reading

WednesdayNov 01, 2023 1:19 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Announces Entry into Multinational Distribution Agreement in the Middle East

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0), a leading Swiss hosted secure and private communications platform, today announced that it has signed a major distribution agreement with a distributor in the Hashemite Kingdom of Jordan and the Republic of Iraq in order to distribute its entire Sekur Swiss-hosted private and encrypted communications platform. According to the announcement, Sekur’s distribution agreement was signed with Solutions Communications & Security Systems (“SOLCOM”), a Jordanian corporation from Amman, Jordan, and is valid for a period of 12 months, with renewal options for additional 12 months. “We are thrilled to have signed this…

Continue Reading